|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 809586-809595 of 2348881 (234889 Page(s) Totally)
<< < 80954 80955 80956 80957 80958 80959 80960 80961 80962 80963 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2024-03-07 |
Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer
|
Ma, L;Chen, C;Zhao, CX;Li, T;Ma, LY;Jiang, JY;Duan, ZJ;Si, Q;Chuang, TH;Xiang, R;Luo, YP |
| 國家衛生研究院 |
2012-04 |
Targeting cathepsin S induces tumor cell autophagy via the EGFR-Erk signaling pathway
|
Chen, KL;Chang, WS;Cheung, CH;Lin, CC;Huang, CC;Yang, YN;Kuo, CP;Kuo, CC;Chang, YH;Liu, KJ;Wu, CM;Chang, JY |
| 國家衛生研究院 |
2011-04 |
Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway
|
Chen, KL;Chang, WSW;Lin, CC;Cheung, CHA;Kuo, CP;Kuo, CC;Chang, YH;Liu, KJ;Chang, JY |
| 國立成功大學 |
2012-04-01 |
Targeting cathepsin S induces tumor cell autophagy via the EGFR-ERK signaling pathway
|
Chen, Kuo-Li; Chang, Wun-Shaing Wayne; Cheung, Chun Hei Antonio; Lin, Chun-Cheng; Huang, Chien-Chang; Yang, Yung-Ning; Kuo, Chang-Po; Kuo, Ching-Chuan; Chang, Yi-Hsun; Liu, Ko-Jiunn; Wu, Ching-Ming; Chang, Jang-Yang |
| 國家衛生研究院 |
2024-05-09 |
Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function
|
Lee, HW;Chen, SJ;Tsai, KJ;Hsu, KS;Chen, YF;Chang, CH;Lin, HH;Hsueh, WY;Hsieh, HP;Lee, YF;Chiang, HC;Chang, JY |
| 國立成功大學 |
2024-05-9 |
Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function
|
Lee;Hao-Wei;Chen;Szu-Jung;Tsai;Kuen-Jer;Hsu;Kuei-Sen;Chen;Yi-Fan;Chang;Chih-Hua;Lin;Hsiao-Han;Hsueh;Wen-Yun;Hsieh;Hsing-Pang;Lee;Yueh-Feng;Chiang;Huai-Chueh;Chang;Jang-Yang |
| 中山醫學大學 |
2015-06-04 |
Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells.
|
CC, Yu;FW, Hu;CH, Yu;MY, Chou |
| 臺大學術典藏 |
2022-02-21T02:51:54Z |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali P.A.; Lin C.-C.; Carthon B.C.; Bauer T.M.; Tucci M.; Italiano A.; Iacovelli R.; Su W.-C.; Massard C.; Saleh M.; Daniele G.; Greystoke A.; Gutierrez M.; Pant S.; YING-CHUN SHEN; Perrino M.; Meng R.; Abbadessa G.; Lee H.; Dong Y.; Chiron M.; Wang R.; Loumagne L.; L?pine L.; De Bono J. |
| 臺大學術典藏 |
2022-02-21T23:31:30Z |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali, Paolo Andrea; Chia-Chi Lin; Carthon, Bradley C.; Bauer, Todd M.; Tucci, Marcello; Italiano, Antoine; Iacovelli, Roberto; Su, Wu Chou; Massard, Christophe; Saleh, Mansoor; Daniele, Gennaro; Greystoke, Alastair; Gutierrez, Martin; Pant, Shubham; YING-CHUN SHEN; Perrino, Matteo; Meng, Robin; Abbadessa, Giovanni; Lee, Helen; Dong, Yingwen; Chiron, Marielle; Wang, Rui; Loumagne, Laure; Lépine, Lucie; De Bono, Johann |
| 國立成功大學 |
2022 |
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: Results from a phase I/II open-label, multicenter study
|
Zucali, P.A.;Lin, C.-C.;Carthon, B.C.;Bauer, T.M.;Tucci, M.;Italiano, A.;Iacovelli, R.;Su, W.-C.;Massard, C.;Saleh, M.;Daniele, G.;Greystoke, A.;Gutierrez, M.;Pant, S.;Shen, Y.-C.;Perrino, M.;Meng, R.;Abbadessa, G.;Lee, H.;Dong, Y.;Chiron, M.;Wang, R.;Loumagne, Loumagne L.;L�pine, L�pine L.;De, Bono J. |
Showing items 809586-809595 of 2348881 (234889 Page(s) Totally)
<< < 80954 80955 80956 80957 80958 80959 80960 80961 80962 80963 > >>
View [10|25|50] records per page
|
